The purpose of this study is to better understand the long-term health effects of Pompe disease and to determine if there are any abnormal changes in the brain and peripheral nerves. Additionally, the investigators will study the relationship between the abnormal changes in brain, nervous system findings, and developmental outcomes. The investigators will collect clinical information from clinic visits as well as assessments such as neuroimaging (magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI)), cognition, academic skills, speech and language function, physical therapy and quantitative muscle ultrasound. Subjects will be in this study for at least 3 years and up to 6 years.
Study Type
OBSERVATIONAL
Enrollment
45
Duke University Medical Center
Durham, North Carolina, United States
To determine the involvement of central nervous system (CNS) pathology in long-term survivors of IPD and early diagnosed LOPD patients being treated with enzyme replacement therapy (ERT) as measure by neuroimaging.
Time frame: up to 6 years
To further investigate developmental outcomes, such as cognition, language, academic skills and fine motor skills, of children with Pompe disease as reported by patient performance report measures.
Time frame: up to 6 years
To further investigate developmental outcomes, such as cognition, language, academic skills and fine motor skills, of children with Pompe disease as reported by parent report measures.
Time frame: up to 6 years
To characterize the motor speech function in children with IPD and LOPD as reported auditory-perceptual and instrumental methods.
Time frame: up to 6 years
To investigate the relationship between neuroimaging findings and developmental outcomes, over time, for children with Pompe disease, as reported by .
Time frame: up to 6 years
To investigate the extent of muscle pathology, especially myopathy and neuropathy in the distal lower extremities, using screening questionnaires.
Time frame: up to 6 years
To investigate the extent of muscle pathology, especially myopathy and neuropathy in the distal lower extremities, using quantitative muscle ultrasound.
Time frame: up to 6 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.